YU103A - Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju - Google Patents

Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju

Info

Publication number
YU103A
YU103A YU103A YUP103A YU103A YU 103 A YU103 A YU 103A YU 103 A YU103 A YU 103A YU P103 A YUP103 A YU P103A YU 103 A YU103 A YU 103A
Authority
YU
Yugoslavia
Prior art keywords
ppm
inert gas
solution
bottles
less
Prior art date
Application number
YU103A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Francois Dietlin
Daniele Fredj
Original Assignee
Pharmatop Scr.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8851012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmatop Scr. filed Critical Pharmatop Scr.
Publication of YU103A publication Critical patent/YU103A/sh

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0005—Degasification of liquids with one or more auxiliary substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Removal Of Specific Substances (AREA)
YU103A 2000-06-06 2001-06-06 Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju YU103A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007231A FR2809619B1 (fr) 2000-06-06 2000-06-06 Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention

Publications (1)

Publication Number Publication Date
YU103A true YU103A (sh) 2006-05-25

Family

ID=8851012

Family Applications (1)

Application Number Title Priority Date Filing Date
YU103A YU103A (sh) 2000-06-06 2001-06-06 Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju

Country Status (16)

Country Link
US (1) US6992218B2 (fr)
CN (1) CN1556694A (fr)
AP (1) AP1880A (fr)
AU (1) AU2001266120A1 (fr)
CA (1) CA2415403C (fr)
CZ (1) CZ200313A3 (fr)
DZ (1) DZ3384A1 (fr)
FR (1) FR2809619B1 (fr)
MA (1) MA26926A1 (fr)
MX (1) MXPA03000001A (fr)
NZ (1) NZ523458A (fr)
PE (1) PE20030508A1 (fr)
RU (1) RU2003100090A (fr)
TW (1) TWI237570B (fr)
WO (1) WO2001093830A1 (fr)
YU (1) YU103A (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
FR2832063B1 (fr) * 2001-11-15 2004-08-27 Aguettant Lab Procede de production de solutions stables de substances phenoliques et les solutions en resultant
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
US20050020554A1 (en) * 2003-06-06 2005-01-27 Ahmed Salah U. Stability of hormone formulations
CN1882338A (zh) 2003-09-18 2006-12-20 马库赛特公司 经巩膜递送
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
WO2006086744A1 (fr) 2005-02-09 2006-08-17 Macusight, Inc. Formulations pour un traitement oculaire
DE102005037653A1 (de) * 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
FR2894154B1 (fr) * 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.
JP5528708B2 (ja) * 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
ES2563288T3 (es) 2006-03-23 2016-03-14 Santen Pharmaceutical Co., Ltd Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
CA2628806C (fr) 2006-07-18 2012-08-21 Genfarma Laboratorio S.L. Formulation liquide injectable de paracetamol
EP1992334A1 (fr) * 2007-05-08 2008-11-19 Docpharma NV/SA Formule stable pour le stockage de médicament phénolique sensible à l'oxydation, spécialement le paracétamol, et qui comprend une solution de médicament aqueuse désoxygénée par le processus de fabrication à température contrôlée de la formule
DE102007026975A1 (de) * 2007-06-01 2008-12-04 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Antioxidationsmittel für Lebensmittel
WO2009047634A2 (fr) * 2007-06-18 2009-04-16 Combino Pharm, S.L. Préparations aqueuses d'acétaminophène pour injection
AR067047A1 (es) * 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
WO2009064928A1 (fr) 2007-11-13 2009-05-22 Cadence Pharmaceuticals Acétaminophène par voie intraveineuse en dose réduite
EP2307056B1 (fr) * 2008-01-17 2021-12-15 Pharmis Biofarmacêutica, LDA Compositions pharmaceutiques aqueuses stables contenant du paracetamol
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
US20110097470A1 (en) * 2008-06-11 2011-04-28 Joerg Kowalczyk Highly active antioxidant based on trehalulose
EP2243477A1 (fr) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracétamol destiné à l'administration parentérale
EP2464332B2 (fr) 2009-08-13 2025-10-15 Neogen N.V. Procédé de production d'une formulation de paracétamol en solution aqueuse stable en stockage
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
EP2481464A4 (fr) 2009-09-24 2014-03-12 Toshiba Kk Solution absorbant le dioxyde de carbone gazeux
WO2011071400A1 (fr) 2009-12-10 2011-06-16 Tecnimede - Sociedade Técnico-Medicinal, S.A. Procédé et composition pour préparation de formulations liquides stables de paracétamol
US20110207824A1 (en) * 2010-02-25 2011-08-25 Moly Pharma Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution
US9089477B2 (en) 2011-02-10 2015-07-28 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
PL3287123T3 (pl) 2011-03-04 2020-11-02 Grünenthal GmbH Wodny preparat farmaceutyczny tapentadolu do podawania doustnego
ES2414557B1 (es) * 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
CN103006550A (zh) * 2012-12-11 2013-04-03 哈药集团三精制药股份有限公司 一种胞磷胆碱钠注射液及其制备方法
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
BR102014005885B1 (pt) 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
WO2016008546A1 (fr) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Formulation aqueuse comprenant du paracétamol et de l'ibuprofène
CN104288099B (zh) * 2014-09-25 2017-02-15 西安仁仁药业有限公司 一种布洛芬注射液的制备方法
HRP20190231T1 (hr) 2015-03-27 2019-04-05 Grünenthal GmbH Stabilna formulacija za parenteralnu primjenu tapentadola
LT3701944T (lt) 2015-06-18 2022-04-11 Estetra Srl Burnoje disperguojamas dozavimo vienetas, kurio sudėtyje yra estetrolio komponentas
ES2671160T3 (es) 2015-06-18 2018-06-05 Mithra Pharmaceuticals S.A. Unidad de dosificación orodispersable que contiene un componente estetrol
EP3120837A1 (fr) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Solution de bortezomib prêts à l'emploi
WO2017134540A1 (fr) 2016-02-05 2017-08-10 Innopharma, Inc. Procédé de fabrication d'une poche pour perfusion intraveineuse stable et prête à l'emploi pour une formulation sensible à l'oxydation
CA3037810A1 (fr) 2016-09-23 2018-03-29 Grunenthal Gmbh Formulation stable pour l'administration parenterale de tapentadol
WO2018140894A1 (fr) 2017-01-30 2018-08-02 Nevakar, Inc Compositions de norépinéphrine et procédés associés
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
WO2018192664A1 (fr) * 2017-04-20 2018-10-25 Hyloris Developments Sa Procédé de préparation d'une composition à faible teneur en oxygène dissous, comprenant de l'acétaminophène, et éventuellement un ou plusieurs ains, et une composition obtenue à partir de celui-ci
WO2019150381A1 (fr) * 2018-02-01 2019-08-08 Joshi Mahendra R Composition pharmaceutique stable et procédé de production d'une injection de chlorhydrate d'isoprotérénol
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
SG11202009725XA (en) 2018-04-19 2020-11-27 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
US11911517B2 (en) 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
US12171717B2 (en) * 2018-10-08 2024-12-24 Merz Pharma Gmbh & Co. Kgaa Neurotoxin prefilled vial
US10478453B1 (en) 2019-01-15 2019-11-19 Exela Pharma Sciences, LLC Stable, highly pure L-cysteine compositions for injection and methods of use
EP4114336A1 (fr) 2020-03-06 2023-01-11 Baxter International Inc. Système de récipient scellé conditionné de stockage stable de formulation pharmaceutique sensible à l'oxygène
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN113105040A (zh) * 2021-04-02 2021-07-13 武汉工控工业技术研究院有限公司 一种自然水体无菌处理及长期保存技术
CN116803376B (zh) * 2023-08-04 2024-02-13 广州白云山星群(药业)股份有限公司 一种复方愈创木酚磺酸钾口服溶液的制备方法
CN119745847A (zh) * 2025-01-10 2025-04-04 上海上药第一生化药业有限公司 一种盐酸多巴酚丁胺药组合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3443004A (en) * 1965-04-08 1969-05-06 Ciba Geigy Corp Injectable solution containing 6-chloroor 6-trifluoromethyl-7-sulfamyl - 1,2,4-benzothiodiazine-1,1-dioxide diuretic
DD153578A1 (de) * 1980-10-22 1982-01-20 Hans Meffert Stabilisierung von oxydationsempfindlichen wirkstoffen,vorrangig dithranol in arzneizubereitungen
RO93391B (ro) * 1984-12-20 1988-03-31 Eli Lilly And Company Procedeu pentru prepararea unor saruri de dobutamina
AU5405894A (en) * 1992-10-21 1994-05-09 Alcon Laboratories, Inc. Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery
WO1994013274A1 (fr) * 1992-12-10 1994-06-23 Abbott Laboratories Solutions de catecholamines stabilisees
FR2740338B1 (fr) * 1995-12-01 1997-12-05 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees contenant de la dobutamine
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention

Also Published As

Publication number Publication date
TWI237570B (en) 2005-08-11
CN1556694A (zh) 2004-12-22
AP2002002711A0 (en) 2002-12-31
DZ3384A1 (fr) 2001-12-13
RU2003100090A (ru) 2004-05-10
NZ523458A (en) 2005-08-26
FR2809619B1 (fr) 2004-09-24
PE20030508A1 (es) 2003-06-25
CZ200313A3 (cs) 2003-11-12
MXPA03000001A (es) 2004-03-19
MA26926A1 (fr) 2004-12-20
FR2809619A1 (fr) 2001-12-07
AP1880A (en) 2008-08-19
CA2415403C (fr) 2011-05-24
CA2415403A1 (fr) 2001-12-13
AU2001266120A1 (en) 2001-12-17
US6992218B2 (en) 2006-01-31
WO2001093830A1 (fr) 2001-12-13
US20040054012A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
YU103A (sh) Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju
Scheffer O2 requirements for growth and survival of wood-decaying and sapwood-staining fungi
DE60206378D1 (de) Chlorogensäure enthaltender geschmacksmodifizierender stoff
CN108771961B (zh) 一种生物酶除甲醛剂及其应用
CY1110480T1 (el) Ενεσιμο υγρο σκευασμα παρακεταμολης
ITPD20130052A1 (it) Procedimento di vinificazione e prodotto per uso enologico atto ad essere utilizzato in detto procedimento di vinificazione
ES2237133T3 (es) Procedimiento de tratamiento para material de corcho y tapones de corcho.
BR0015688B1 (pt) método para gerar uma mistura gasosa fisiologicamente ativa não-inflamável, e, aparelho para gerar uma mistura gasosa fisiologicamente ativa não-inflamável.
Mottram et al. Influence of ascorbic acid and pH on the formation of N‐nitrosodimethylamine in cured pork containing added dimethylamine
DE60003057D1 (de) Verfahren zur extraktion mit einem überkritischen fluid
Okayama Effect of modified gas atmosphere packaging after dip treatment on myoglobin and lipid oxidation of beef steaks
IL148797A (en) Metal-binding compounds and uses thereof
ES2383438T3 (es) Procedimiento de tratamiento del corcho o de un material a base de corcho con un gas inerte a una presión estrictamente inferior a 1 Mpa
CN102634972B (zh) 一种重度污染丝织品文物替代样的制备方法
DE502007004128D1 (de) Verfahren zur Herstellung von lagerstabilen Lösungen aus Pelargonium-Extrakten
Shih et al. Solvent sublation of hexachlorobutadiene and 2, 4, 6-trichlorophenol
EP0351145B1 (fr) Méthode d'imprégnation de bâtonnet de bois
ES8400484A1 (es) Un metodo para la extraccion selectiva de 2 acidos del lupulo.
HK1254526A1 (zh) 熏蒸系统及方法
JP4131365B2 (ja) 木材の保存処理方法および保存処理木材
Tsachaki et al. Dynamics of flavour release from ethanolic solutions
Horvat et al. Effect of tannin addition on the efficacy of bentonite fining and the quality of Malvazija istarska (Vitis vinifera L.) wine
RU2134527C1 (ru) Способ предотвращения заплесневения табака
Rodríguez et al. Ozone as a Sanitation Method in Winemaking: Improving Fermentation Control in the Context of Climate Change
YAO et al. Effect of hyperbaric oxygen preconditioning on activation of plasma protein C in a rat model of asphyxial cardiac arrest-resuscitation